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ABSTRACT
Neuronal degeneration in spinal muscular atrophy
(SMA) is caused by reduced expression of the
survival of motor neuron (SMN) protein. The SMN
protein is ubiquitously expressed and is present
both in the cytoplasm and in the nucleus where it
localizes in Cajal bodies. The SMN complex plays an
essential role for the biogenesis of spliceosomal
U-snRNPs. In this article, we have used an RNA
interference approach in order to analyse the effects
of SMN depletion on snRNP assembly in HeLa cells.
Although snRNP profiles are not perturbed in SMN-
depleted cells, we found that SMN depletion gives
rise to cytoplasmic accumulation of a GFP-SmB
reporter protein. We also demonstrate that the SMN
protein depletion induces defects in Cajal body
formation with coilin being localized in multiple
nuclear foci and in nucleolus instead of canonical
Cajal bodies. Interestingly, the coilin containing foci
do not contain snRNPs but appear to co-localize
with U85 scaRNA. Because Cajal bodies represent
the location in which snRNPs undergo 20-O-methyla-
tion and pseudouridylation, our results raise the
possibility that SMN depletion might give rise to a
defect in the snRNA modification process.
INTRODUCTION
Spinal muscular atrophy (SMA) is a common human genetic
disease in which degeneration of the motor neurons of
the spinal cord results in subsequent muscular atrophy. The
SMA disease results from deletions or mutations in the sur-
vival of motor neurons (SMN1) gene (1). The SMN protein
is ubiquitously expressed in all tissues of metazoan organisms
reﬂecting the fact that it provides a fundamental activity
required by all cells. The protein is present both in the cyto-
plasm and in the nucleus, where it localizes in Cajal bodies
both in vivo and in cultured cells, although in some cell
lines it is also found in separate bodies called gems (gemini
of coiled bodies) (2,3). SMN and several associated proteins
called Gemins form a macromolecular complex involved in
the biogenesis of various ribonucleoproteins, such as
snoRNPs, the spliceosomal U-snRNPs and the telomerase
ribonucleoprotein complex (4–6).
In addition to its function in RNP assembly, the SMN pro-
tein might also play a role in nucleocytoplasmic, dendritic
or axonal transport. Indeed, the SMN protein colocalizes
with cytoskeletal proteins in dendrites and axons of spinal
cord motoneurons in vivo (7–9). Moreover, SMN localizes
in motile granules that are located in neurites and growth
cones of cultured neurons (10). Taken together, these results
suggest that SMN may be actively transported into neuronal
processes and could have a motor neuron-speciﬁc function.
Concerning the role of the SMN protein in snRNP biogen-
esis, it has been shown that the SMN complex is required
both for the formation of the Sm core complex and the asso-
ciation of this complex to the U1, U2, U4 and U5 snRNAs
(11–13). During this process, SMN interacts with the Sm
core proteins by binding to the sDMA rich C-terminal
domains of SmB, SmD1 and SmD3 (5,14). The sDMAs
modiﬁcations in the Sm proteins are carried out by the
methylosome, a complex containing the PRMT5 methyltrans-
ferase, which allows the transfer of modiﬁed Sm proteins to
the SMN complex and the association of the Sm core com-
plex to the snRNA (5). Moreover, several observations sug-
gest a role for the SMN complex in generating snRNPs that
are competent for nuclear import. Indeed, assembly of spli-
ceosomal snRNPs is a stepwise process that follows an
ordered pathway [for a review, see (15)]. After transcription
by RNA polymerase II, the snRNAs are exported to the cyto-
plasm where they associate with the Sm proteins. This bind-
ing induces hypermethylation of the snRNA 7-methyl cap by
a methylase to form methyl-2,2,7-guanosine cap structure,
thereby generating an snRNP bipartite nuclear localization
signal, composed of the Sm core complex and the snRNA
cap structure. It has been shown that SMN associates with
snRNP throughout the cytoplasmic phase of this pathway
suggesting that SMN might play multiple functions in
snRNP assembly and snRNP nuclear import (11,16–19). In
order to deﬁne more precisely the roles of the SMN complex
in the snRNPs assembly pathway, we used an RNA interfer-
ence approach to generate SMN-depleted HeLa cells. In this
report, we show that depletion of SMN affects Sm core
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indicating that snRNP biogenesis is required for the
formation of these nuclear structures. Our results point also
to a potential link between a defect in the snRNA post-
transcriptional modiﬁcation process and SMA pathogenesis.
MATERIALS AND METHODS
RNA interference, Cell culture and transfection
Design of target-speciﬁc siRNA duplexes were performed as
described (20) and selected siRNA sequences corresponding
to regions 313–331 and 402–420 of the SMN mRNA
sequence were generated. Control siRNAs include scrambled
siRNA and an siRNA generated against the sequence of the
ﬁreﬂy luciferase.
HeLa cells were grown at 37 Ci n5 %C O 2 and in DMEM
containing 10% fetal calf serum. Cells were transfected with
the siRNA duplex using Lipofectamine reagent (Invitrogen)
according to the manufacturer’s protocol. Hela cell extracts
were prepared according to the protocol described previously
(21). For preparation of whole cell extracts, HeLa cells from
suspension cultures were harvested and lysed for 30 min
on ice in HNTG buffer (20 mM HEPES pH 7.9, 150 mM
NaCl, 1% Triton, 30% glycerol, 1 mM MgCl2, 1 mM
EDTA, 1 mM PMSF and Proteases inhibitors). After centrifu-
gation at 18000g (10 min, 4 C), supernatents were used for
western analysis or immunoprecipitation experiments.
Immunofluorescence microscopy, western and
northern analyses
Immunoﬂuorescence was performed on cells grown on
coverslips, washed in PBS and ﬁxed in 4% (wt/vol) paraform-
aldehyde in PBS at room temperature (RT) followed by per-
meabilization with 0.1% Triton X100 in PBS for 5 min at RT.
Anti-SMN (Transduction Laboratories) were diluted 1/2000
and p80 coilin was detected with polyclonal rabbit anti-coilin
antibody (1/400 dilution). Anti-m3G antibodies (K121) were
purchased from Calbiochem and used at 1/1000 dilution
for immunoﬂuorescence. Anti-SmB antibodies (ANA125,
Cappel) were diluted at 1/100 for IF and 1/500 for western
analysis. Incubations were for 1 h at 25 C in PBS containing
2% BSA, and slides were then washed three times for 3 min
in PBS. Secondary antibodies were diluted according to
manufacturer instructions. Coverslips were mounted on glass
slides using mounting medium (Vectashield) and samples
were observed using a Leica ﬂuorescence microscope.
Images were acquired with a Coolsnap camera (Photomet-
rics) controlled by the software Metamorph (Universal
Imaging).
The protein content of the fractions was determined using
BCA protein assay kit (Pierce) and equal amounts of proteins
from each lysate were analyzed as described previously (22).
Detection was carried out by enhanced chemiluminescence
(Pierce). Glycerol gradient centrifugation, immunoprecipita-
tion experiments and northern analyses were as described
previously (23,24).
Fluorescent in situ hybridization
Synthesis and labelling of antisense U85 RNA probe was per-
formed as described (25). HeLa cells were washed twice in
1· PBS and ﬁxed for 20 min at room temperature in 4%
paraformaldehyde followed by overnight permeabilization
at 4 C in 70% ethanol. Cells were then washed twice in
2· SSC 50% formamide at room temperature and hybridized
overnight at 37 Ci n4 0ml of a mixture containing 10%
Dextran sulfate, 2 mM vanadyl-ribonucleoside complex,
0.02% RNAse free BSA, 40 mg Escherischia coli tRNA,
2 · SSC, 50% formamide, 60 ng of labelled probe. Cells
were then washed four times for 30 min in 2· SSC,
50% formamide at 37 C and rehydrated three times 5 min
in 1· PBS. Immunoﬂuorescence was performed as described
above.
Preparation of nuclear and cytoplasmic extracts
Hela cells were removed from dishes by trypsinization and
washed twice with ice-cold PBS. Cells were resuspended
at  5 · 10
6/ml in HMKE buffer (20 mM Hepes pH 7.2,
10 mM KCl, 5 mM MgCl2, 1 mM EDTA and 250 mM
sucrose) containing protease inhibitor cocktail (complete
EDTA free, Roche), phenylmethylsulfonyl ﬂuoride (PMSF
1 mM) and digitonin (200 mg/ml). Cells were left on ice
for 10 min and then centrifuged at 500g for 10 min at 4 C,
to separate cytosol from membranes, nuclei, organelles
and cytoskeleton. The supernatant (cytosol) was carefully
removed, and the pellet was washed in HMKE buffer without
digitonin. To perform nuclear protein extraction, the pellet
was solubilized in extraction buffer (0.1 M Tris–HCl pH 9,
0.1 M NaCl, 5 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2,
0.5% NP-40 and protease inhibitor cocktail) for 20 min
on ice. The samples were then centrifuged at 15 000g for
10 min at 4 C and the supernatant (Nuclear fraction) was
carefully removed.
RESULTS
Knockdown of SMN expression in HeLa cells by
RNA interference
Target-speciﬁc siRNA duplexes of 19 nt RNAs with symmet-
ric 2 nt dT 30 overhangs were selected from the SMN open
reading frame and transfected, as well as a control siRNA
into Hela cells. To verify correct SMN depletion, cells were
harvested, extracts prepared and examined for SMN levels by
western blotting. As shown in Figure 1A and as monitored by
quantiﬁcation analysis (Figure 1B), introducing the siRNA
duplex targetting region 313–331 of the SMN mRNA gives
rise, after 48 or 72 h, to a decrease in SMN protein level of
70–80% compared with the control while levels of GAPDH
protein remained unchanged. Similar results were obtained
using another siRNA targetting region 402–420 of the SMN
mRNA sequence (data not shown) and the decrease of
the SMN protein amount is speciﬁc to SMN siRNAs since
control siRNA against ﬁreﬂy luciferase or a scrambled
siRNA have no effects on SMN protein levels (Figure 1A).
In order to conﬁrm correct depletion of the SMN protein,
cells were subjected to immunoﬂuorescence studies using
anti-SMN antibodies. As expected, in control cells, the
SMN protein localized diffusely into the cytoplasm and
concentrated in Cajal bodies while in SMN-depleted cells,
80–90% of cells no longer showed cytoplasmic or Cajal
bodies ﬂuorescence (Figure 1C).
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glycerol gradient
In order to test whether SMN depletion might give rise to glo-
bal defects in the assembly of snRNPs, we examined snRNP
complexes in extracts by glycerol gradient sedimentation.
Following centrifugation, the RNA of odd-numbered frac-
tions was phenol-extracted and separated on a denaturing
polyacrylamide gel. After transfer to a nylon membrane, the
blots were then probed with
32P-labelled oligonucleotides
complementary to the spliceosomal snRNAs. As shown in
Figure 2, identical snRNP proﬁles were observed in extracts
prepared from both SMN-depleted and control cells: free U6
snRNPs are found in fractions 3–7, the U4/U6 snRNPs sedi-
mented in fractions 9–15 and the multi-U4/U6/U5 snRNPs
migrated near the bottom of the gradient in fractions 21–25.
U2 and U1 snRNPs were also similarly distributed in both
type of cells, being localized in fractions 5–9/13–15 and
5–9 respectively. These results show that snRNPs proﬁles
are not perturbed upon SMN depletion in HeLa cells.
Cytoplasmic retention of a GFP-SmB fusion protein
upon SMN depletion
Numerous in vitro studies revealed a cytoplasmic role for the
SMN protein in the formation of the heptameric Sm core
complex and in the association of this complex to the
snRNA (5). Accordingly, recent reports showed that knock-
down of components of the SMN complex by RNAi inhibited
Sm core assembly (26–28). We assumed therefore that
depletion of SMN would hinder formation of the Sm core
complex in the cytoplasm affecting subsequently the nuclear/
cytoplasmic ratio of Sm proteins. Immunoﬂuorescence stud-
ies using anti-SmB antibodies did not allow the detection of
a signiﬁcant cytoplasmic accumulation of endogenous SmB
(data not shown). In order to visualize a defect in Sm core
assembly, we followed the localization of a GFP-SmB fusion
protein in the SMN-depleted cells. The GFP-SmB fusion pro-
tein was chosen because it does not contain a nuclear local-
ization determinant, in contrast to the SmD1 and SmD3
proteins, indicating that nuclear import and localization into
speckles and Cajal bodies is due to incorporation into snRNPs
(22,29,30). As shown in Figure 3 and as expected, a speckled
distribution and Cajal bodies staining were observed upon
transfection of a GFP-SmB plasmid into HeLa cells previ-
ously treated with a control siRNA. Interestingly, transfection
of the GFP-SmB construct in SMN-depleted cells did not
give rise to the clear speckled distribution and Cajal bodies
localization of the fusion protein but produced a cytoplasmic
accumulation as visualized by an increased ﬂuorescence of
this compartment (Figure 3, lower panels). Quantiﬁcation of
these experiments indicated that up to 60–70% of cells show
increased cytoplasmic ﬂuorescence in SMN-depleted cells
while only 25–35% of cells present this phenotype in control
cells. These results demonstrate that cells without SMN dis-
play defects in GFP-SmB protein localization, consistent with
an inhibition in cytoplasmic Sm core protein assembly.
Depletion of SMN induces defects in Cajal bodies
formation
Using anti-coilin antibodies, the immunoﬂuorescence studies
shown in Figure 3 also revealed that the SMN-depleted cells
display a decreased number and less intense Cajal bodies
when compared with control cells. In order to check more
precisely this phenotype, we repeated these experiments
using both anti-SMN and anti-coilin antibodies. As shown
in Figure 4A and as expected, the SMN protein is found in
the cytoplasm and colocalizes with coilin in several nucleo-
plasmic punctuate structures representing canonical Cajal
bodies in 70–80% of control HeLa cells (upper panels). In
contrast, in SMN-depleted cells (Figure 4A, lower panels),
neither cytoplasmic nor nuclear staining was observed using
anti-SMN antibodies while small and multiple coilin-positive
foci became visible upon anti-coilin staining in 60–70% of
cells. The lack of canonical Cajal bodies in SMN-depleted
cells is not a consequence of a decrease in the amount of
coilin since our western analysis showed that both control
and SMN-depleted cells contain equivalent levels of the
Figure 1. Depletion of SMN in Hela cells using an RNAi approach (A)
western blot analysis on SMN-depleted cells. An siRNA duplex has been
transfected into Hela cells for the indicated time, and extracts were prepared
and examined for SMN levels by western blotting using anti-SMN antibodies.
A control siRNA was introduced into HeLa cells under similar conditions.
The GAPDH protein was used as a loading control. (B) Quantification of
SMN protein amounts. Blots were scanned and quantified using ImageQuant
software (Molecular Dynamics). The percentage of SMN levels with respect
to control is shown. (C) Immunofluorescence studies on SMN-depleted and
control Hela cells using anti-SMN antibodies. In control cells, the SMN
protein localizes to the cytoplasm and to Cajal bodies, while cytoplasmic and
Cajal bodies fluorescence are no longer visible in the SMN-depleted cells.
The nucleus was stained with DAPI. Note that the cell presenting Cajal bodies
staining in the SMN-depleted cells (right panel) has not taken up the siRNA
and can be considered as a control cell.
Nucleic Acids Research, 2006, Vol. 34, No. 10 2927p80-coilin protein (data not shown). Moreover, examination
of the localization of coilin in SMN-depleted cells indicated
also a redistribution of coilin protein into the nucleolus.
Indeed, as shown in Figure 4B, coilin accumulated only in
Cajal bodies in control cells (panels a–d) while in SMN-
depleted cells, coilin was dispersed over the nucleoplasm in
residual Cajal bodies and could also be found in nucleoli
(panels e–h). It appears that coilin accumulated adjacent
to the ﬁbrillarin marker of the dense ﬁbrillar region since
staining did not cover exactly the same parts of the nucleolus
(Figure 4B, panel g). These results demonstrate that the
SMN protein is required for correct Cajal body formation
and restrained localization of coilin into these structures.
snRNPs do not localize to residual Cajal bodies in
SMN-depleted cells
Previous studies indicated that coilin depletion gives rise
to residual Cajal bodies unable to recruit snRNPs and the
SMN complex (31–33). To determine whether the residual
Cajal bodies observed in SMN-depleted cells contained
spliceosomal snRNPs, we stained both control and SMN-
depleted cells with anti-coilin antibodies and with anti-m3G
antibodies, the latter recognizing the m3G cap of mature
snRNAs. As shown in Figure 5, in control HeLa cells, the
m3G cap epitope colocalized with coilin into the canonical
Cajal bodies conﬁrming that snRNPs are found in these struc-
tures (29,34). In addition, a diffuse nucleoplasmic m3G stain-
ing was also observed and corresponded to localization
of snRNPs in speckles that are compartments enriched of
pre-messenger RNA splicing factors (35). In SMN-depleted
cells, residual Cajal bodies are visualized by coilin immuno-
ﬂuorescence while anti-m3G antibodies staining produced a
diffuse nucleoplasmic and nuclear speckled distribution sug-
gesting that snRNPs are located in speckles (Figure 5, lower
panels). However, this m3G staining did not co-localize with
the positive-coilin foci indicating that upon SMN depletion,
the residual Cajal bodies do not contain snRNPs.
The U85 scaRNA is located in residual Cajal bodies
Previous studies demonstrated that Cajal bodies contain small
Cajal body-speciﬁc RNAs (scaRNAs) that function in the
post-transcriptional modiﬁcation of polII-speciﬁc spliceo-
somal snRNAs (25,36,37). Because it appears that snRNPs
do not colocalize with residual Cajal bodies bodies in
SMN-depleted cells, we investigated the intracellular local-
ization of the U85 scaRNA upon SMN depletion. Owing to
the low amount of endogenous U85 scaRNAs, cells were
co-transfected with a plasmid encoding the U85 gene (25)
together with the siRNA duplex and used in in situ experi-
ments after 48 h growth. As shown in Figure 6 (upper
panels), probing of control Hela cells using a ﬂuorescent
Figure 2. Glycerol gradient sedimentation of snRNPs. Extracts prepared from SMN-depleted (siRNA-SMN) and control cells (control) after 60 h were analyzed
by glycerol gradient centrifugation and fractions were recovered. The RNA was extracted, run on denaturing polyacrylamide gels and transferred to a nylon
membrane for northern analysis using
32P-labelled oligonucleotide probes specific for U1, U2, U4, U5 and U6 snRNAs. The fraction number and the positions of
the different snRNP complexes are shown at the bottom.
Figure 3. Depletion of SMN hinders the efficient nuclear import of a
transiently expressed GFP-SmB fusion protein. After transfection of Hela
cells with a siRNA duplex specific to SMN or a control siRNA for 36 h, cells
were transfected with a plasmid encoding a GFP-SmB gene. After 24 h, cells
were fixed and the subcellular localization of the GFP-SmB fusion protein
was then observed by fluorescence microscopy. Cajal bodies were visualized
by immunofluorescence using anti-coilin antibodies. As shown in the upper
panels, in control cells, the GFP fusion protein localizes to the nuclear
compartment and in Cajal bodies while in the SMN-depleted cells (lower
panels), a cytoplasmic accumulation of the GFB-SmB fusion protein is
observed.
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strong stained dots in the nucleoplasm and these dots also
reacted with anti-p80 coilin antibodies showing that they cor-
respond to canonical Cajal bodies. In SMN-depleted cells, the
p80-coilin antibodies allowed the staining of multiple small
and faint foci corresponding to the residual Cajal bodies
and interestingly, these dots were also visible with the U85
antisense probe (Figure 6, lower panels), suggesting that the
U85 scaRNA accumulates with the residual Cajal bodies.
DISCUSSION
The SMN protein plays essential roles in the production of
spliceosomal snRNPs during the cytoplasmic stages of this
pathway (4,5). The SMN protein also localizes in the nucleo-
plasm in structures called Cajal bodies, which are important
for the maturation of RNPs (38). Previous in vitro studies
with extracts of SMN-depleted cells conﬁrmed that SMN is
required for efﬁcient Sm core assembly (26–28). In this
study, we report that a lower Sm assembly activity is also
obtained in vivo upon SMN depletion. Indeed, while we
failed to detect a strong defect in the nuclear import of endo-
genous Sm proteins, we found that a transiently transfected
GFP-SmB fusion protein does not localize clearly in speckles
and Cajal bodies and accumulates in the cytoplasm in SMN-
depleted but not in control cells. This effect is not because of
a difference in the amount of GFP-SmB fusion protein
expressed in both type of cells since similar levels are present
Figure 4. SMN-depleted cells contain numerous foci reacting with coilin antibodies. (A) Immunofluorescence studies with antibodies directed against coilin and
SMN were performed on control cells and on SMN-depleted cells. In control cells, coilin and SMN localizes to canonical Cajal bodies while these structures
become dispersed in SMN-depleted cells where coilin localizes to numerous nucleoplasmic foci. Zooms of representative cells corresponding to the insets are
represented at the right. (B) Relocalization of coilin into nucleoli upon SMN depletion. Immunofluorescence studies with coilin allows the detection of Cajal
bodies in control cells while fibrillarin is found primarily in nucleoli and also in Cajal bodies (white arrows, panel b). In SMN-depleted cells (lower panels),
coilin is found in residual Cajal bodies and in nucleoli (white arrows, panel h) which are stained by fibrillarin (panels f–g). The nucleus was stained with DAPI.
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conceivable that the visualization of cytoplasmic GFP-SmB
upon SMN depletion results from the saturation of the Sm
core/snRNP assembly machine due to limiting amount of
SMN, the saturation threshold being not reachable in control
cells with normal SMN levels.
In addition to its role in Sm core assembly, it has been pro-
posed that the SMN protein plays a role in the snRNP nuclear
import process. Indeed, using a digitonin-permeabilized
in vitro cell system, it was shown that import of labeled U1
snRNPs is dependent on SMN indicating that SMN and
snRNP nuclear imports are coupled in vitro (18). The fact
that we could not detect cytoplasmic snRNP accumulation
in SMN-depleted HeLa cells in our RNAi experiments
could be be due to the rapid degradation of the snRNA that
is unable to associate to a complete Sm core complex. An
instability of the non-assembled snRNA is consistent with
studies in yeast showing that depletion of a unique Sm protein
inhibits Sm core assembly and leads to degradation of
U-snRNAs (39). It is also possible that, in vivo, snRNPs are
imported into the nucleus by multiple pathways. The exist-
ence of various import routes for snRNPs can be compared
with the import pathways of ribosomal proteins whose nuc-
lear localization signals are represented by an accumulation
of basic aminoacids and which can be imported by four
different transporters (40). It is noteworthy that the nuclear
localization signal of the snRNP common core proteins is
represented by a basic rich protuberance (22), which could
be recognized by other nuclear import receptors in the
absence of SMN.
Our inability to detect clear in vivo loss-of function defects
in snRNP assembly in SMN-depleted cells could also be due
to the fact that snRNPs are very stable and have long half-life
of >60 h (41). It is therefore conceivable that snRNPs are
recycled many times, hindering analysis of effects on newly
synthesized snRNPs. Alternatively, it is also possible that
depletion of SMN gives rise to more subtle defects in the
Sm core complex and snRNP assembly processes and that
these defects do not generate snRNP instability or snRNP
cytoplasmic accumulation. Although puriﬁed Sm proteins
assemble on snRNAs in an ordered pathway in vitro (42),
the SMN machinerie could play a role in controlling the spe-
ciﬁcity and stochiometry of Sm proteins in the heptameric
ring complex. Depletion of the SMN protein could therefore
lead to a defect in a ‘quality control’ process, which would
generate abnormal heptameric Sm core complexes that
would not obligatorily be hindered in their association to
snRNAs. Such a defect could subsequently generate several
types of aberrant snRNPs, being defective at different steps
in the snRNP biogenesis pathway. For example, an aberrant
Sm core complex lacking the SmE protein would still be
able to associate with an snRNA, be substrate for the Tgs1
hypermethylase (recognizing the C-tails of SmB and SmD1
proteins) and the resulting snRNPs able to be imported in
the nucleus and to localize into Cajal bodies and speckles.
Similarly, a snRNP lacking SmB would still be recognized
by the Tgs1 enzyme (owing to the interaction of the enzyme
with SmD1) and also be competent for nuclear import. How-
ever, these aberrant snRNPs could be partially deleterious in
steps affecting spliceosome assembly and/or pre-mRNA spli-
cing. The formation of multiple abnormal snRNPs, being still
able to follow a correct snRNP biogenesis pathway, could
explain the difﬁculties to see prominent loss-of-functions
defects in snRNP formation and subcellular localization in
SMN-depleted cells.
Figure 5. snRNPs do not localize in residual Cajal bodies observed in
SMN-depleted cells. To determine the localization of snRNPs, control cells
and SMN-depleted cells were subjected to immunofluorescence studies
using anti-p80 coilin (red) and anti-m3G antibodies (green). In control cells,
snRNPs accumulate into Cajal bodies and into speckles while in SMN-
depleted cells, snRNPs are not located into residual Cajal bodies but are
found in a diffuse speckled distribution.
Figure 6. In situ localization of U85 scaRNA. A plasmid containing human U85 scaRNA was transfected into HeLa cells with control or SMN specific siRNA
duplexes and after 48 h, cells were subjected to in situ hybridization using a Cy3-fluorescent probe specific to U85 (red). The canonical Cajal bodies in control
cells and the residual Cajal bodies in SMN-depleted cells were visualized with anti-p80 coilin antibody staining (green).
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cence techniques, we could detect that canonical Cajal
bodies visible in wild-type cells were replaced by numerous
nuclear coilin-positive foci. Consistent with our data, a
recent study report that reduction in the levels of proteins
from the SMN complex affects Cajal bodies homeostasis
(27). These results suggest that the SMN protein is required
for correct Cajal bodies formation and extend to SMN the
previous observations that coilin has a crucial role in deﬁn-
ing Cajal body structure. Indeed, characterization of coilin
knockout MEF cells revealed that residual Cajal bodies
are formed in the absence of full-length coilin protein
(32). These structures do not contain spliceosomal snRNPs
and the SMN protein, but accumulate ﬁbrillarin and
Nopp140, two nucleolar markers as well as the U3 snoRNA
(32,37). Moreover, separate coilin-positive Cajal bodies
without SMN and SMN positive foci lacking coilin have
been observed in DFSF1 cells after injection of ﬂuorescent
tagged coilin or SMN proteins (30). A second type of
residual Cajal body accumulating scaRNAs and Sm snRNAs
but not the other nucleolar markers has also been found in
coilin knockout MEF cells (37). Our ﬁndings that SMN
depletion affects Cajal bodies formation in HeLa cells are
also consistent with other studies showing that reduction
in expression of the SMN complex is associated with a fail-
ure in the assembly of nuclear bodies. Indeed, immuno-
cytochemical analysis of ﬁbroblasts from type I SMA
patients indicates a signiﬁcant reduction in the number of
gems and a correlation of the number of gems with clinical
severity (43). In addition, immunoﬂuorescence microscopy
experiments on spinal cord of SMA fetuses show that nuc-
leus from cells no longer present SMN-containing foci
although Cajal body staining was detectable using ﬁbrillarin
antibodies (44). Moreover, by homozygous deletion of the
SMN exon 7 in neurons of mice affected with an SMA
phenotype, it was shown that the mutated SMN protein
has a defect in nuclear targeting leading to a defect in
formation of nuclear bodies (45). Altogether, these data
indicate that SMN plays a critical role in the production
and composition of Cajal bodies.
Based on the fact that SMN knock-down leads to forma-
tion of residual Cajal bodies containing the U85 scaRNA
but not snRNPs, it is tempting to propose that the modiﬁca-
tion process of internal residues in snRNAs might be defect-
ive in SMN-depleted cells. Indeed, it was shown that Cajal
bodies are the subnuclear structures in which scaRNAs
perform 20-O-methylation and pseudouridylation at internal
residus of spliceosomal snRNAs (36,37,46). It was also
shown that several 20-O-methylated and pseudouridylated
residues in U2 snRNA are important for spliceosome forma-
tion and for efﬁcient splicing (47). It is therefore conceiv-
able that a defect in the modiﬁcation process of snRNA
internal residues could result in nuanced splicing perturba-
tions of particular pre-mRNAs and to inefﬁcient and/or
incorrect production of speciﬁc proteins in motoneurons
of SMA patients. Such a model could also explain why
SMN mutations affect speciﬁcally motoneurons. Given that
snRNPs are very stable (see above), our preliminary experi-
ments could not allow us to determine whether this process
is affected in HeLa cells upon SMN depletion and other
studies are clearly needed to address this question. In this
regard, the biochemical defects responsible for the SMA
disease are not well understood, and a long unanswered
question was to know whether SMA pathogenesis is linked
to SMN defects in snRNP biogenesis. A response has
recently been provided by an elegant study showing that
reduction of SMN levels impairs snRNP assembly and
causes motor axon degeneration in zebraﬁsh embryos (28).
Remarkably, a compensation of motor axon defects in the
embryos is observed upon injection of puriﬁed human or
Xenopus U snRNPs demonstrating a link between motor
axon degeneration and snRNP assembly defects. The use
of this experimental system with snRNPs reconstituted
using in vitro transcribed snRNAs and thus lacking modiﬁed
residues will clearly be helpful to characterize a correlation
between a defect in the production of modiﬁed residues in
snRNAs and motor axon degeneration.
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